Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MIrikizumab in UC - a Real-woRld prOspective multicenteR Registry

NCT06696014 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT06696014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06696014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MIrikizumab in UC - a Real-woRld prOspective multicenteR Registry
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Terminated
Start date
May 8, 2025
Completion date
July 8, 2026
Enrollment
6 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis